• Users Online: 265
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

Lenalidomide with dexamethasone to multiple myeloma patients relapsing from bortezomib-based induction therapies: A prospective, observational study

Tan Tran-Der, Hong Ying-Chung, Li Sin-Syue, Yu Jui-Ting, Sung Yung-Chuan, Wang Po-Nan, Teng Chieh-Lin Jerry

Year : 2020| Volume: 63| Issue : 5 | Page no: 211-217

   This article has been cited by
 
1 Dexamethasone/lenalidomide
Reactions Weekly. 2021; 1845(1): 157
[Pubmed]  [Google Scholar] [DOI]
2 Case Report: Lenalidomide as a Second-Line Treatment for Bortezomib-Ineffective Nephrotic Syndrome Caused by LCDD: 2 Case Reports and a Literature Review
Xin Zhang,Xiao-juan Yu,Su-xia Wang,Fu-de Zhou,Ming-hui Zhao
Frontiers in Medicine. 2021; 8
[Pubmed]  [Google Scholar] [DOI]
3 Pomalidomide and Dexamethasone Are Effective in Relapsed or Refractory Multiple Myeloma in a Real-Life Setting: A Multicenter Retrospective Study in Taiwan
Yu-Chin Hung,Jyh-Pyng Gau,Shang-Yi Huang,Bor-Sheng Ko,Chieh-Lin Jerry Teng
Frontiers in Oncology. 2021; 11
[Pubmed]  [Google Scholar] [DOI]

 

Read this article